SEC Form 4 · accession 0001209191-19-008083
CONCERT PHARMACEUTICALS, INC. · CNCE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nancy Stuart
Officer — Chief Operating Officer
Period of report
Feb 6, 2019
Accepted (ET)
Feb 7, 2019 · 4:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367920
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 6, 2019 | M | 28,616 | $4.41 | A | 116,724 | D | |
| Common Stock | Feb 6, 2019 | F | 9,046 | $13.95 | D | 107,678 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $4.41 | Feb 6, 2019 | M | 28,616 | D | — | Dec 10, 2019 | Common Stock | 28,616 | 5,896 | D |
Explanation of responses
- F1This option is fully vested.